|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.47 USD | +0.76% |
|
-1.50% | -18.90% |
USANA Health Sciences, Inc. reported earnings results for the fourth quarter ended December 30, 2023. For the fourth quarter, the company reported sales was USD 221.08 million compared to USD 227.96 million a year ago. Net income was USD 16.77 million compared to USD 12.8 million a year ago.
Diluted earnings per share from continuing operations was USD 0.87 compared to USD 0.66 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.90% | 836M | |
| +8.20% | 7.78B | |
| +0.34% | 7.38B | |
| +10.20% | 6.52B | |
| -8.10% | 3.67B | |
| -13.13% | 3.44B | |
| -14.57% | 1.17B | |
| +8.34% | 934M | |
| -42.27% | 879M | |
| +0.32% | 711M |
USANA HEALTH SCIENCES, INC. 
